Botulinum toxin has recently been approved by the United States FDA for idiopathic and neurogenic detrusor overactivity (overactive bladder). This is an easy clinic procedure that can be performed cystoscopically under local anesthesia with very good success. We will discuss the mechanism of action of this drug, the efficacy, and clinical precautions to ensure a safe and successful result for t...

Language can impact emotion, even when it makes no reference to emotion states. For example, reading sentences with positive meanings ("The water park is refreshing on the hot summer day") induces patterns of facial feedback congruent with the sentence emotionality (smiling), whereas sentences with negative meanings induce a frown. Moreover, blocking facial afference with botox selectively slow...

Start End Topic Speakers 09:00 09:05 Introduction  Carlos D'Ancona 09:05 09:20 Contribution of radiology in the diagnosis of BPO  Enrico Finazzi Agro 09:20 09:35 What information does urodynamic provide?  Ervin Kocjancic 09:35 09:50 Clinical treatment of BPO  Carlos D'Ancona 09:50 10:05 Is it possible to preserve bladder function?  Peter Rosier 10:05 10:30 Discussion All 10:30 11:00 Break ...

Dose-response studies of botulinum toxin for reduction of sweating are sparse in the literature. The aim of this study was to determine the most appropriate concentrations of Botox®, Dysport®, Xeomin® and NeuroBloc®, respectively, in order to achieve the greatest reduction in sweating, thus reducing the costs and increasing the safety of treatment. Four concentrations of each product were inves...

Dental Press J Orthod. 2017 Nov-Dec;22(6):14-24 14 How to cite: Polo M, Artese F, Seixas M, Rivera VLA, Mucha N. An interview with Mario Polo. Dental Press J Orthod. 2017 Nov-Dec;22(6):14-24. DOI: https://doi.org/10.1590/2177-6709.22.6.014-024.int Submitted: September 09, 2017 Revised and accepted: September 22, 2017. I got acquainted to Dr. Mario Polo a couple of years ago through Dr. Mucha, w...